Head-to-head comparison of FDG and radiolabeled FAPI PET: a systematic review of the literature
FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging,
which have demonstrated several advantages over [18F] FDG, especially in the case of low …
which have demonstrated several advantages over [18F] FDG, especially in the case of low …
FAP-targeted PET imaging in gastrointestinal malignancies: a comprehensive review
A Arçay Öztürk, P Flamen - Cancer Imaging, 2023 - Springer
F18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG
PET/CT) plays a crucial role in tumour diagnosis, staging, and therapy response evaluation …
PET/CT) plays a crucial role in tumour diagnosis, staging, and therapy response evaluation …
68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-FAPI PET Observational Trial
L Kessler, N Hirmas, KM Pabst… - Journal of Nuclear …, 2023 - Soc Nuclear Med
The fibroblast activation protein (FAP) is highly expressed on carcinoma-associated
fibroblasts in the stroma of pancreatic cancer and thus is a promising target for imaging and …
fibroblasts in the stroma of pancreatic cancer and thus is a promising target for imaging and …
PET/CT FAPI: Procedure and evidence review in oncology: Autores
AP Caresia, JJ Rosales, MR Fraile, AA Öztürk… - Revista Española de …, 2024 - Elsevier
Neoplasms are composed of malignant tumor cells, which are surrounded by other non-
tumor cellular elements, in what has been defined as the microenvironment or tumor stroma …
tumor cellular elements, in what has been defined as the microenvironment or tumor stroma …
Diagnostic performances of PET/CT using fibroblast activation protein inhibitors in patients with primary and metastatic liver tumors: a Comprehensive Literature …
F Manuppella, G Pisano, S Taralli, C Caldarella… - International Journal of …, 2024 - mdpi.com
PET/CT using radiolabeled fibroblast activation protein inhibitors (FAPIs) is a promising
diagnostic tool in oncology, especially when non-increased and/or physiologically high [18F] …
diagnostic tool in oncology, especially when non-increased and/or physiologically high [18F] …
Fibroblast activation protein–directed imaging outperforms 18F-FDG PET/CT in malignant mesothelioma: a prospective, single-center, observational trial
L Kessler, F Schwaning… - Journal of Nuclear …, 2024 - jnm.snmjournals.org
The fibroblast activation protein (FAP) is highly expressed in tumor and stromal cells of
mesothelioma and thus is an interesting imaging and therapeutic target. Previous data on …
mesothelioma and thus is an interesting imaging and therapeutic target. Previous data on …
Recent topics in fibroblast activation protein inhibitor-PET/CT: clinical and pharmacological aspects
Y Nakamoto, S Baba, H Kaida, O Manabe… - Annals of Nuclear …, 2024 - Springer
Recently, positron emission tomography (PET) with fibroblast activation protein inhibitor
(FAPI) has gained significant attention as an advanced tumor diagnostic imaging tool. FAPI …
(FAPI) has gained significant attention as an advanced tumor diagnostic imaging tool. FAPI …
Role of [18F]FAPI-04 in staging and therapeutic management of intrahepatic cholangiocarcinoma: prospective comparison with [18F]FDG PET/CT
J Liang, S Jiang, J Song, D Chen, S Weng, S Li… - EJNMMI research, 2024 - Springer
Abstract Background Fluorine-18 fluorodeoxyglucose ([18F] FDG) positron emission
tomography/computed tomography (PET/CT) has some limitations in diagnosis of …
tomography/computed tomography (PET/CT) has some limitations in diagnosis of …
Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)
Y Mori, E Novruzov, D Schmitt, J Cardinale, T Watabe… - npj Imaging, 2024 - nature.com
The discovery of fibroblast activation protein inhibitor positron emission tomography (FAPI-
PET) has paved the way for a new class of PET tracers that target the tumor …
PET) has paved the way for a new class of PET tracers that target the tumor …
Long-Term Outcomes in Radioiodine-Resistant Follicular Cell-Derived Thyroid Cancers Treated with [177Lu]Lu-DOTAGA.FAPi Dimer Therapy
Aim: The study aimed to analyze the long-term outcomes of [177Lu] Lu-DOTAGA. FAPi
dimer therapy in individuals diagnosed with radioiodine-resistant (RAI-R) follicular cell …
dimer therapy in individuals diagnosed with radioiodine-resistant (RAI-R) follicular cell …